Purchase Order FA864925P0323
- Not listed
- <p>The U.S. Air Force Research Laboratory (AFRL) awarded a $70,888 Small Business Innovation Research (SBIR) Program Phase I firm-fixed-price purchase order to Theralytix LLC, a for-profit organization, for the clearance of pathogens causing diarrhea, dysentery, and urinary tract infections. The award was made on June 26, 2024, with an ultimate completion date of September 24, 2024. The contract is set aside for small businesses.</p>
- The Department of the Air Force Materiel Command Research Laboratory awarded a $749,991 firm fixed price purchase order to Definitive Biotechnologies, LLC as part of the Small Business Innovation Research Program Phase II Action. Under this contract, Definitive Biotechnologies will deliver a disposable, multiplex molecular device for simultaneous point-of-care diagnosis of coronavirus disease 2019 and influenza. The contract has a total small business set aside designation. Performance will...
- This is a firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Charlot Biosciences Inc., a minority-owned, self-certified small disadvantaged business. The $49,869 contract is for the SBIR (Small Business Innovation Research) Program Phase I development of a system for rapid pathogen threat detection in aerial and field environments. The award is set aside for small businesses. Charlot Biosciences Inc. has received multiple SBIR awards from the Department of the...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Glydertech, Incorporated, a self-certified small disadvantaged business. The contract, valued at $1,249,998.00, is for the development of a rapid multiplex detection system for respiratory diseases to protect critical strategic assets. The contract has a completion date of July 21, 2024 and is a firm-fixed-price purchase order. This SBIR Phase II award builds upon...
- <p>This is a $109,979.00 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Qore Health Inc., a self-certified small disadvantaged business, for the delivery of deployable hospital-grade diagnostics for combat care in contested environments. This award is part of the STTR Phase I research program and has a total small business set-aside designation. The contract is scheduled for completion by September 3, 2024.</p>
- The U.S. Air Force Research Laboratory (AFRL) awarded a $74,766.00 Small Business Innovation Research (SBIR) Phase I contract to Ora Biomedical, Inc., a minority-owned and small disadvantaged business, to identify therapeutics to improve the health of astronauts in space. The firm-fixed-price purchase order contract has a period of performance through August 19, 2024. This award is part of the AFRL's efforts to support small businesses in developing innovative technologies to address...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Selas Bio, LLC, a minority-owned, small disadvantaged, and service-disabled veteran-owned business. The contract, worth $109,876.00, is for research and development under the STTR (Small Business Technology Transfer) program. The contract was awarded on May 17, 2024, with a planned completion date of August 19, 2024. It is a firm-fixed-price purchase order, which...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $74,959 firm fixed-price purchase order to Rizlab Health Inc., a small business, to develop a wireless portable electronic hematology analyzer for infection and sepsis stratification on the battlefield. This Phase I SBIR contract supports Rizlab's research into rapid diagnostic technologies, particularly portable blood count analyzers. Rizlab has received multiple awards from federal agencies like the Department of Health and Human Services...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $74,437 firm fixed price purchase order to Safetraces Inc. under the Small Business Innovation Research Program Phase I solicitation. This contract will support the development of safe aerosol simulants to verify removal of toxic particles in United States Air Force facilities, with work to be completed by August 3, 2023 at Safetraces's facility in Pleasanton, California. As a total small business set-aside, this SBIR...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $900,000 firm fixed price definitive contract to Innovator Health LLC of Englewood, Ohio. The contract is for COVID-19 dual-use defense technologies and solutions under the Small Business Innovation Research Program Phase II solicitation. As a total small business set aside, Innovator Health will deliver innovative defense technologies with clear Air Force applications to address needs arising from the coronavirus...
The Air Force Research Laboratory awarded a $1.24 million firm fixed-price purchase order to Theralytix LLC, a small business, for Phase II of the Small Business Innovation Research (SBIR) Program. The contract supports research and development efforts focused on the clearance of pathogens causing diarrhea, dysentery, and urinary tract infections. Work will be performed at the contractor's facility in Reno, Nevada, with an ultimate completion date of April 26, 2027. This award represents a Total Small Business set-aside, ensuring the opportunity is reserved exclusively for small business concerns. Theralytix LLC will advance technology development under this SBIR Phase II award, building upon successful Phase I research to further develop solutions for pathogen mitigation and clearance. The Air Force Research Laboratory's investment in this infectious disease research aligns with the Department of Defense's broader interest in medical countermeasures and operational health readiness. As a Phase II SBIR award, this contract represents a significant step toward commercialization and practical application of the contractor's technology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2m | 7/24/25 |